Weight-loss Drugs May Cause Alarming Nail Loss, Study Finds

WHO:

Fox News - Dr. Marc Siegel, senior medical analyst; Dr. Charles Taïeb, clinical dermatologist at Necker University Hospital in Paris; Dr. Bruno Halioua, Paris dermatologist.

Fox News - 575 users of GLP-1 drugs and a control group of 1,329 non-users.

WHAT:

Fox News - Research presented at the European Academy of Dermatology and Venereology (EADV) Congress 2026 revealed that 39% of GLP-1 users reported nail detachment compared to 9% of non-users.

Fox News - 46% of GLP-1 users experienced nail discoloration, while 17% of the control group reported the same.

Fox News - 66% of GLP-1 users reported experiencing at least one nail disorder, compared to 53% of the control group.

Fox News - 50% of GLP-1 users reported unusual hair loss, compared to 34% of the control group.

Fox News - 26% of GLP-1 users reported hair loss or thinning after starting treatment, compared to 12% of non-users.

Fox News - 42% of GLP-1 users experienced loss of hair volume, compared to 19% of non-users.

Fox News - Patients taking GLP-1 receptor agonists were more than four times as likely to report nail detachment compared to non-users with similar medical profiles.

WHERE:

Fox News - Research participants were recruited across France, the U.S., Brazil, and Mexico.

Fox News - The study findings were presented at the EADV Congress in Vienna, Austria.

WHEN:

Fox News - The research was presented on Oct. 1, 2026.

WHY:

Fox News - Researchers found that weight loss alone did not explain the difference in nail and hair issues between GLP-1 users and non-users.

Fox News - Dr. Halioua suggested that scalp inflammation may be involved, indicating a potential inflammatory component beyond classical shedding after rapid weight loss.

HOW:

Fox News - The studies evaluated user-reported data from GLP-1 users and a control group at a single point in time.

(UPDATED October 8, 2026 16:05 UTC)

Research presented at the European Academy of Dermatology and Venereology Congress revealed that users of GLP-1 drugs reported significantly higher rates of nail and hair disorders compared to non-users, with 39% experiencing nail detachment and 50% reporting unusual hair loss. The study, which included participants from France, the U.S., Brazil, and Mexico, found that 66% of GLP-1 users experienced at least one nail disorder, while 42% reported a loss of hair volume. Researchers noted that weight loss alone could not explain these differences, suggesting that scalp inflammation might play a role in these side effects.